The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,156.00
Bid: 12,154.00
Ask: 12,156.00
Change: 168.00 (1.40%)
Spread: 2.00 (0.016%)
Open: 12,254.00
High: 12,256.00
Low: 12,052.00
Prev. Close: 11,988.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS SUMMARY: Peel Hunt Cuts Grafton After Warning

Thu, 17th Oct 2019 09:30

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

----------

FTSE 100

----------

GOLDMAN CUTS ROLLS-ROYCE PRICE TARGET TO 1196 (1232) PENCE - 'CONVICTION BUY'

----------

INVESTEC RAISES AVIVA TO 'BUY' ('ADD') - TARGET 455 (385) PENCE

----------

BARCLAYS RAISES ST JAMES'S PLACE PRICE TARGET TO 1241 (1155) P - 'OVERWEIGHT'

----------

CS RAISES NATIONAL GRID TO 'OUTPERFORM' (NEUTRAL) - PRICE TARGET 970 (810) PENCE

----------

HSBC RAISES ASTRAZENECA PRICE TARGET TO 6235 (5180) PENCE - 'REDUCE'

----------

JEFFERIES CUTS ROYAL DUTCH SHELL PRICE TARGET TO 2780 (2900) PENCE - 'BUY'

----------

JEFFERIES CUTS BP PRICE TARGET TO 590 (625) PENCE - 'BUY'

----------

GOLDMAN CUTS ANGLO AMERICAN TARGET TO 2300 (2450) PENCE - 'CONVICTION BUY LIST'

----------

GOLDMAN CUTS GLENCORE PRICE TARGET TO 210 (220) PENCE - 'NEUTRAL'

----------

GOLDMAN CUTS RIO TINTO PRICE TARGET TO 5100 (5250) PENCE - 'BUY'

----------

GOLDMAN CUTS BHP GROUP PRICE TARGET TO 1900 (2100) PENCE - 'NEUTRAL'

----------

GOLDMAN RAISES ANTOFAGASTA PRICE TARGET TO 950 (850) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS ANTOFAGASTA PRICE TARGET TO 750 (810) PENCE - 'UNDERWEIGHT'

----------

JPMORGAN CUTS BURBERRY GROUP PRICE TARGET TO 1950 (2000) PENCE - 'NEUTRAL'

----------

FTSE 250

----------

PEEL HUNT CUTS GRAFTON GROUP TO 'HOLD' ('ADD') - TARGET 800 (860) PENCE

----------

JEFFERIES CUTS BELLWAY TO 'HOLD' ('BUY') - TARGET 3743 (3875) PENCE

----------

UBS CUTS WEIR GROUP TO 'NEUTRAL' ('BUY') - TARGET 1450 (1550) PENCE

----------

HSBC CUTS WEIR GROUP PRICE TARGET TO 1820 (1870) PENCE - 'BUY'

----------

RBC CUTS RATHBONE BROTHERS PRICE TARGET TO 2450 (2500) PENCE - 'SECTOR PERFORM'

----------

RBC RAISES LANCASHIRE HOLDINGS PRICE TARGET TO 775 (750) PENCE - 'OUTPERFORM'

----------

BERENBERG CUTS CENTAMIN PRICE TARGET TO 113 (120) PENCE - 'HOLD'

----------

HSBC RAISES WIZZ AIR PRICE TARGET TO 3250 (3100) PENCE - 'HOLD'

----------

HSBC RAISES EASYJET PRICE TARGET TO 1450 (1300) PENCE - 'BUY'

----------

BERENBERG RAISES IBSTOCK PRICE TARGET TO 310 (300) PENCE - 'BUY'

----------

GOLDMAN CUTS KAZ MINERALS TO 'NEUTRAL' ('BUY') - TARGET 475 (675) PENCE

----------

OTHER MAIN MARKET AND AIM

----------

BERENBERG RAISES ASOS PRICE TARGET TO 3000 (2500) PENCE - 'HOLD'

----------

BERENBERG RAISES FORTERRA PRICE TARGET TO 310 (290) PENCE - 'HOLD'

----------

Copyright 2019 Alliance News Limited. All Rights Reserved.

More News
13 Feb 2024 09:32

LONDON BROKER RATINGS: Citi lifts GSK; Shore likes XPS Pensions

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
12 Feb 2024 12:04

LONDON MARKET MIDDAY: FTSE 100 underperforms as European peers rise

(Alliance News) - London's FTSE 100 underwhelmed on Monday, with some of its largest constituents pulling it lower, while indices in Europe were on the up on favourable comments on interest rate cuts by a European Central Bank official.

Read more
12 Feb 2024 09:41

LONDON BROKER RATINGS: Deutsche Bank starts Deliveroo at 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
12 Feb 2024 09:12

Barclays sees "compelling" entry point at AstraZeneca after recent falls

(Sharecast News) - Barclays has kept an 'overweight' position on AstraZeneca despite the biopharma group's disappointing annual results last week, saying that the stock's recent underperformance provides an attractive entry point for investors.

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
9 Feb 2024 07:51

LONDON BRIEFING: Barclays buys Tesco's retail banking business

(Alliance News) - Stocks in London are called to open higher on Friday, closing off a busy corporate week.

Read more
8 Feb 2024 17:00

LONDON MARKET CLOSE: Softer earnings weigh on underperforming FTSE 100

(Alliance News) - London's FTSE 100 ended lower on Thursday, with mixed corporate updates keeping a lid on enthusiasm, while in New York the S&P 500 has the 5,000 point mark in touching distance.

Read more
8 Feb 2024 14:42

London close: Stocks slip as US jobless claims fall

(Sharecast News) - London markets experienced a downturn in trading on Thursday, with stocks relinquishing earlier gains as investors processed a decrease in jobless claims in the United States.

Read more
8 Feb 2024 12:08

LONDON MARKET MIDDAY: DS Smith surges on takeover approach from Mondi

(Alliance News) - Stock prices in London were mixed at midday Thursday, as markets struggled to find direction amid a mixed wave of corporate updates and earnings.

Read more
8 Feb 2024 08:59

LONDON MARKET OPEN: Unilever up on buyback; BAT ups dividend

(Alliance News) - THE FTSE 100 in London opened slightly higher on Thursday, with earnings from British American Tobacco and Unilever boosting the index.

Read more
8 Feb 2024 08:44

TOP NEWS: AstraZeneca confident after 2023 profit more than doubles

(Alliance News) - AstraZeneca PLC on Thursday said it expects another year of strong growth after reporting pretax profit in 2023 more than doubled.

Read more
8 Feb 2024 07:58

AstraZeneca shares slip as Q4 profits miss forecasts

(Sharecast News) - Biopharma titan AstraZeneca delivered a 6% increase in sales in 2023 despite a $3.7bn decline in Covid-19 medicines revenues, as it guided to a strong pick-up in growth this year - though profits came in slightly under analysts' forecasts.

Read more
8 Feb 2024 07:50

LONDON BRIEFING: Unilever sets new buyback; Astra profit surges

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye a busy day of earnings.

Read more
2 Feb 2024 08:38

AstraZeneca celebrates latest successful trial of acoramidis in Japan

(Alliance News) - AstraZeneca PLC on Friday said positive results from a Phase 3 trial of acoramidis are consistent with global findings, bring the drug closer to regulatory submission in Japan.

Read more
2 Feb 2024 06:22

TOP NEWS: US sends drugmakers initial offers in Medicare price talks

(Alliance News) - The US government said it was making initial offers to drugmakers Thursday as part of Medicare negotiations meant to lower the prices many older Americans would pay for 10 medicines.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.